What is the appropriate antimicrobial regimen for an adult with Salmonella typhi isolated from blood culture?

Treatment of Salmonella Typhi Bacteremia

First-Line Antibiotic Recommendation

For adults with Salmonella typhi isolated from blood culture, initiate azithromycin 500 mg once daily for 7-14 days as the preferred first-line treatment, given its superior clinical outcomes with lower failure rates (OR 0.48), shorter hospital stays, and dramatically lower relapse risk (OR 0.09) compared to alternatives. 1, 2

Treatment Algorithm by Clinical Severity

Uncomplicated Disease (Stable Vital Signs, No Organ Dysfunction)

• Azithromycin 500 mg PO once daily for 7-14 days is the optimal choice 1, 2
• Azithromycin demonstrates 95.7% susceptibility among S. Typhi isolates and relapse rates <3% when full courses are completed 3, 1
• Expect fever clearance within 4-5 days of initiating therapy 1, 2

Severe Disease (Sepsis, Hemodynamic Instability, ICU-Level Care)

• Ceftriaxone 2g IV once daily for 14 days is the preferred agent for severe presentations 4, 2
• Ceftriaxone maintains 100% susceptibility against S. Typhi isolates, including those from Asia where fluoroquinolone resistance exceeds 70% 3, 4
• Relapse rates with ceftriaxone are <8% when given for adequate duration 3, 1

Critical Geographic Considerations

Never use fluoroquinolones empirically for patients with recent travel to South or Southeast Asia, where ciprofloxacin resistance approaches 70-97%. 3, 1, 2

• More than 70% of S. Typhi isolates imported into the UK are fluoroquinolone-resistant 3
• In endemic regions like Nepal and Pakistan, 89-97% of isolates show resistance or reduced susceptibility to ciprofloxacin 5, 6, 7
• Fluoroquinolones remain acceptable only for fully sensitive strains from sub-Saharan Africa 1, 2

Treatment Duration to Prevent Relapse

Complete the full 14-day antibiotic course regardless of clinical improvement to minimize relapse risk, which occurs in 10-15% of inadequately treated cases. 3, 1

• Azithromycin for 7 days shows relapse rates <3%, but extending to 14 days further reduces risk 3, 1
• Ceftriaxone requires 14 days to achieve relapse rates <8% 3, 4
• Complications such as intestinal perforation and encephalopathy occur in 10-15% of patients with illness duration >2 weeks 3, 1

Alternative Regimens When First-Line Unavailable

If Azithromycin Unavailable or Contraindicated

• Ceftriaxone 1-2g IV/IM daily for 7-14 days (can transition to oral cefixime for completion, though cefixime has reported failure rates of 4-37.6%) 3, 2

If Both Azithromycin and Ceftriaxone Unavailable

• Consider conventional first-line antibiotics (ampicillin, chloramphenicol, cotrimoxazole) only if susceptibility is confirmed, as recent data shows 97.8% susceptibility in some regions 5, 8
• Do not rely on historical resistance patterns—verify current susceptibility 5, 8

Diagnostic Pitfalls to Avoid

Never rely on the Widal test for diagnosis or treatment decisions, as it has poor specificity (68.44%) and very poor positive predictive value (5.7%). 1, 2

• Blood cultures remain the gold standard with 40-80% sensitivity in the first week 3, 1, 2
• Collect blood cultures before starting antibiotics whenever possible 1
• Stool and urine cultures become positive only after the first week of illness 3

Fluoroquinolone Resistance Detection

When testing isolates for fluoroquinolone sensitivity, ciprofloxacin disc testing alone is unreliable—the organism must also be sensitive to nalidixic acid to be considered truly fluoroquinolone-susceptible. 3

• Nalidixic acid resistance correlates strongly with reduced ciprofloxacin susceptibility (MIC >0.25 mg/L) 6
• 76% of isolates in Nepal showed nalidixic acid resistance, correlating with reduced ciprofloxacin susceptibility 6

Monitoring Clinical Response

Expected Timeline

• Fever should clear within 4-7 days with appropriate therapy 4, 1, 2
• Average hospital stay is 8-12 days depending on severity 4

When to Reassess

If fever persists beyond 48-72 hours of appropriate antibiotic therapy in a clinically stable patient, investigate for complications or alternative diagnoses rather than empirically changing antibiotics. 1

• Complications requiring surgical intervention include intestinal perforation (success rates up to 88.2% with simple excision and closure) 1
• Watch for gastrointestinal bleeding, encephalopathy, hepato-renal failure, and myocarditis 4

Common Adverse Effects

Azithromycin

• Gastrointestinal symptoms: nausea, vomiting, abdominal pain, diarrhea 1
• Monitor for QT-prolonging drug interactions 1

Ceftriaxone

• Generally well-tolerated with minimal adverse effects 4
• Monitor for hypersensitivity reactions 4

Special Populations

Immunocompromised Patients (CD4+ <200 cells/µL)

• Extend treatment duration to 2-6 weeks rather than standard 7-14 days 2
• Consider ceftriaxone over azithromycin for severe immunosuppression 2

Pediatric Dosing

• Azithromycin: 20 mg/kg/day (maximum 1g/day) for 7 days 1
• Ceftriaxone: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days 1

Public Health Considerations

Notify state/local health departments, as typhoid fever is a nationally notifiable disease requiring public health reporting. 2

• 81% of US cases report recent international travel 3, 2
• Chronic carriage occurs in 3-5% of patients, with gallstones significantly prolonging fecal shedding 9
• Typhoid vaccines (oral Ty21a or parenteral Vi-polysaccharide) are 50-80% effective and recommended for close contacts and future travelers 2